A recent global study led by researchers from CU Medicine and HKUMed has discovered a hepatitis C virus drug “simeprevir” as a potent treatment for COVID-19, which can strongly suppress the replication of SARS-CoV-2. The combination of this drug with remdesivir can result in drug synergism and generate an even more effective outcome.
The universities of Sheffield, Leeds and Manchester are launching a new investment company to help boost the commercialisation of university spinouts and start-ups in the North of England.
CUHK Vice-Chancellor Prof. Rocky S. Tuan joined the International Higher Education Forum 2021 hosted by the Universities UK International on 14 April 2021 to look at the challenges universities are facing and what they have learned from the pandemic.
Established in January 2020 by a generous donation from the Perivoli Foundation, the Perivoli Africa Research Centre (PARC) represents the University of Bristol's cross-disciplinary commitment to championing transformation in research and partnership to advance Africa's achievement of its own aspirations.
Please join us as we convene a diverse community of academics, policy actors and global thought leaders to consider pathways to achieving PARC’s mission to transform research and partnerships between Africa and the global North.
the University of Cape Town’s (UCT) Associate Professor Zarina Patel launched the New African Urban University, a one-year project funded by the Worldwide Universities Network’s (WUN) Research Development Fund.
Associate Professor Patel, from UCT's Department of Environmental and Geographical Science in the Faculty of Science, is the principal investigator on the project, leading a team of members from nine WUN-member universities across the world.
The New African Urban University project will forge new partnerships aimed at strengthening the role of African universities in urban change and this will take place during four workshops throughout the year, focused on knowledge exchange and agenda-setting.
At the first global online forum for university leaders, hosted by Zhejiang University in China, presidents from 56 universities across six continents have committed to working together to meet sustainable development goals (SDGs). The initiative includes five key aspects which all signatories have agreed to: implementing the concept of sustainable development, improving sustainable development competence, supporting scientific research in response to global challenges, working with global partners to provide innovative solutions and constructive transnational cooperation on specific issues.
Among the top 50 universities on the QS World University Rankings, 80% have developed their university-level sustainability strategy, plans or operational activities. According to Zhaohui Wu, President of Zhejiang University (ZJU), the purpose of the forum was to bring together leaders from some of the best universities to share these visions and best practices on SDGs and explore opportunities for potential cooperation in safeguarding a sustainable future.
The University of Rochester Medical Center (URMC) and Rochester Regional Health (RRH) have begun a new clinical trial that will evaluate the safety and efficacy of a third dose of the Pfizer/BioNTech COVID-19 vaccine. The vaccine is currently approved for a two-dose regimen. This study represents an important step in the development of long-term vaccination strategies to protect against circulating and emerging variants of the virus.
“While widespread vaccination is the key to moving past the current health crisis, COVID-19 has the potential to become a seasonal and mutating virus,” said Ed Walsh, M.D., and infectious disease specialist at URMC. “This study will help us understand important questions about the safety and immunogenicity of multiple doses of an mRNA vaccine, information that could ultimately enable us to extend the protection of vaccines and develop tailor-made, variant-specific boosters.”